Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
Johnson & Johnson asked rival COVID-19 vaccine makers to probe clotting risks
Yahoo/Reuters
Fri, 04/16/21 - 09:47 am
JNJ
Pfizer
BioNTech
Moderna Therapeutics
blood clots
vaccines
COVID-19
Safety concerns with J&J's COVID-19 vaccine present a big opportunity for Pfizer, Moderna: analyst
Fierce Pharma
Fri, 04/16/21 - 12:14 am
JNJ
Moderna Therapeuticcs
Pfizer
BioNTech
vaccines
COVID-19
Inovio’s DNA Vaccine Generates Robust Responses Against COVID-19 Variants in Study
BioSpace
Thu, 04/15/21 - 11:57 pm
Inovio Pharmaceuticals
COVID-19
vaccines
Novartis inks 3rd COVID-19 production pact, this time for Roche's arthritis med Actemra
Fierce Pharma
Thu, 04/15/21 - 11:21 am
Novartis
COVID-19
Pfizer
BioNTech
CureVac
Roche
API
Actemra
Romark eyes FDA okay for COVID antiviral despite mixed trial results
Pharmaforum
Thu, 04/15/21 - 10:49 am
Romark
antivirals
NT-300
clinical trials
COVID-19
Europe won't renew AstraZeneca, Johnson & Johnson COVID-19 vaccine contracts next year: report
Fierce Pharma
Thu, 04/15/21 - 10:40 am
Europe
JNJ
AstraZeneca
COVID-19
vaccines
Merck cans one COVID-19 drug, scraps a clinical trial of another
Fierce Biotech
Thu, 04/15/21 - 10:36 am
Merck
COVID-19
MK-7110
OncoImmune
clinical trials
9 things to know about the J&J, AstraZeneca COVID-19 vaccines & blood clots
Beckers Hospital Review
Thu, 04/15/21 - 10:18 am
JNJ
AstraZeneca
COVID-19
vaccines
blood clots
CDC advisory panel delays decision on Johnson & Johnson Covid-19 vaccine
Stat
Wed, 04/14/21 - 10:23 pm
JNJ
vaccines
COVID-19
CDC
blood clots
Pfizer, BioNTech amp up mRNA vaccine delivery targets amid Johnson & Johnson's delays
Fierce Pharma
Wed, 04/14/21 - 09:41 pm
vaccines
COVID-19
Pfizer
BioNTech
JNJ
drug manufacturing
Moderna and Novavax added to ‘mix and match’ COVID-19 vaccine trial
Marketwatch
Wed, 04/14/21 - 10:37 am
vaccines
COVID-19
Moderna Therapeutics
Novavax
AstraZeneca
Pfizer
BioNTech
clinical trials
Moderna advancing early stage mRNA prospects to show depth beyond COVID-19 shot
Fierce Biotech
Wed, 04/14/21 - 09:38 am
Moderna Therapeutics
vaccines
mRNA-1345
RSV
COVID-19
Former head of FDA’s medical and scientific affairs on Covid: ‘FDA has never been tested like this’
Endpoints
Wed, 04/14/21 - 09:31 am
FDA
pandemic
COVID-19
Anand Shah
Moderna says Covid-19 boosters stand a fighting chance against new variants
Endpoints
Tue, 04/13/21 - 10:06 pm
Moderna Therapeutics
vaccines
COVID-19
COVID-19 variants
Gilead stops Veklury study, citing enrollment challenges, changing treatment
BioPharma Dive
Tue, 04/13/21 - 10:05 pm
Gilead Sciences
COVID-19
remdesivir
Veklury
clinical trials
Feds call halt to Johnson & Johnson COVID-19 vaccine rollout after 'extremely rare' blood clot cases
Fierce Pharma
Tue, 04/13/21 - 10:41 am
JNJ
vaccines
blood clots
COVID-19
FDA
CDC
With variants spreading, Eli Lilly cuts solo COVID-19 antibody out of its U.S. supply deal
Fierce Pharma
Tue, 04/13/21 - 10:35 am
Eli Lilly
COVID-19
antibodies
bamlanivimab-etesevimab
Diasorin heads to the US with $1.8bn Luminex deal
EP Vantage
Tue, 04/13/21 - 10:15 am
Diasorin Molecular
Luminex
diagnostics
M&A
COVID-19
Will Worse Side Effects for Moderna's Vaccine Boost Pfizer's Fortunes?
Motley Fool
Tue, 04/13/21 - 10:13 am
vaccines
COVID-19
Moderna Therapeutics
Pfizer
BioNTech
side effects
COVID player and Pfizer-partnered Valneva eyes $100M Nasdaq IPO
Fierce Biotech
Mon, 04/12/21 - 11:25 pm
Valneva
IPOs
COVID-19
Pfizer
Pages
« first
‹ previous
…
75
76
77
78
79
80
81
82
83
…
next ›
last »